Xenith Biomed develops E coli 157:H7 test:
This article was originally published in Clinica
Executive Summary
Xenith Biomed has begun selling an E coli 157:H7 variant diagnostic system, devised in conjunction with Ireland's National Diagnostic Centre. The Centre has developed an enzyme immunoassay EIA microtitre format, while Rosaveal, County Galway-based Xenith has developed a lateral flow device quick test. Samples require a 16-hour culture before detection using the combined system.